Advertisement

Surgery Approaches in Mesothelioma

  • Andrea Wolf
  • Raja FloresEmail author
Chapter
Part of the Current Cancer Research book series (CUCR)

Abstract

The role of surgical resection in malignant pleural mesothelioma (MPM) is controversial, but cancer-directed surgery has yielded long-term survivors and demonstrated 15% 5-year survival. The two operations developed for surgical resection, extrapleural pneumonectomy (EPP), and radical or extended pleurectomy/decortication (P/D) are described. In addition, this chapter summarizes the preoperative, perioperative, and postoperative management of these patients and the results of studies evaluating both procedures. Data and clinical experience suggest that P/D is better tolerated by patients, and evidence suggests survival is not worse. Although EPP is still performed in selected cases, the authors advocate radical P/D for most patients with MPM.

Keywords

Malignant pleural mesothelioma Surgical resection Extrapleural pneumonectomy Pleurectomy/decortication 

Notes

Conflict of Interest

The authors declare no conflicts of interest to disclose.

References

  1. Aziz T, Jilaihawi A, Prakash D (2002) The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 22:298–305CrossRefPubMedGoogle Scholar
  2. Baldini EH, Richards WG, Gill RR et al (2015) Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 149:1374–1381CrossRefPubMedGoogle Scholar
  3. Batirel HF, Metintas M, Caglar HB et al (2008) Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 3:499–504CrossRefPubMedGoogle Scholar
  4. Burt BM, Cameron RB, Mollberg NM et al (2014) Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg 148:30–35CrossRefPubMedGoogle Scholar
  5. Butchart EG, Ashcroft T, Barnsley WC et al (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31:15–24CrossRefPubMedPubMedCentralGoogle Scholar
  6. Cao C, Tian D, Park J et al (2014) A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 83:240–245CrossRefPubMedGoogle Scholar
  7. Cho BC, Feld R, Leighl N et al (2014) A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the “SMART” approach for resectable malignant pleural mesothelioma. J Thorac Oncol 9:397–402CrossRefPubMedGoogle Scholar
  8. de Perrot M, Feld R, Cho BC et al (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 27:1413–1418CrossRefPubMedGoogle Scholar
  9. de Perrot M, Feld R, Leighl NB et al (2016) Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 151:468–473CrossRefPubMedGoogle Scholar
  10. Flores RM (2005) The role of PET in the surgical management of malignant pleural mesothelioma. Lung Cancer 49(Suppl 1):S27–S32CrossRefPubMedGoogle Scholar
  11. Flores RM, Krug LM, Rosenzweig KE et al (2006) Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1:289–295CrossRefPubMedGoogle Scholar
  12. Flores RM, Zakowski M, Venkatraman E et al (2007) Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2:957–965CrossRefPubMedGoogle Scholar
  13. Flores RM, Pass HI, Seshan VE et al (2008a) Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135:620–626. 6 e1–3CrossRefPubMedGoogle Scholar
  14. Flores RM, Routledge T, Seshan VE et al (2008b) The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 136:605–610CrossRefPubMedGoogle Scholar
  15. Flores RM (2009) Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication. Semin Thorac Cardiovasc Surg 21:149–153CrossRefPubMedGoogle Scholar
  16. Flores RM, Riedel E, Donington JS et al (2010) Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol 5:1649–1654CrossRefPubMedGoogle Scholar
  17. Flores RM (2016) Pleurectomy decortication for mesothelioma: the procedure of choice when possible. J Thorac Cardiovasc Surg 151:310–312CrossRefPubMedGoogle Scholar
  18. Gupta V, Mychalczak B, Krug L et al (2005) Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 63:1045–1052CrossRefPubMedGoogle Scholar
  19. Kindler HL, Karrison TG, Gandara DR et al (2012) Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol 30:2509–2515CrossRefPubMedPubMedCentralGoogle Scholar
  20. Krug LM, Pass HI, Rusch VW et al (2009) Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 27:3007–3013CrossRefPubMedPubMedCentralGoogle Scholar
  21. McCormack PM, Nagasaki F, Hilaris BS et al (1982) Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 84:834–842PubMedGoogle Scholar
  22. Ng JM, Hartigan PM (2008) Anesthetic management of patients undergoing extrapleural pneumonectomy for mesothelioma. Curr Opin Anaesthesiol 21:21–27CrossRefPubMedGoogle Scholar
  23. Pass HI, Temeck BK, Kranda K et al (1997) Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 4:628–633CrossRefPubMedGoogle Scholar
  24. Patz EF Jr, Shaffer K, Piwnica-Worms DR et al (1992) Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 159:961–966CrossRefPubMedGoogle Scholar
  25. Richards WG, Zellos L, Bueno R et al (2006) Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 24:1561–1567CrossRefPubMedGoogle Scholar
  26. Rosenzweig KE, Zauderer MG, Laser B et al (2012) Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 83:1278–1283CrossRefPubMedPubMedCentralGoogle Scholar
  27. Sarot IA (1949) Extrapleural pneumonectomy and pleurectomy in pulmonary tuberculosis. Thorax 4:173–223CrossRefPubMedPubMedCentralGoogle Scholar
  28. Sugarbaker DJ, Flores RM, Jaklitsch MT et al (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117:54–63. discussion p 65CrossRefPubMedGoogle Scholar
  29. Sugarbaker DJ, Jaklitsch MT, Bueno R et al (2004) Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128:138–146CrossRefPubMedGoogle Scholar
  30. Sugarbaker DJ, Wolf AS (2010) Surgery for malignant pleural mesothelioma. Expert Rev Respir Med 4:363–372CrossRefPubMedGoogle Scholar
  31. Sugarbaker DJ, Wolf AS, Chirieac LR et al (2011) Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg 40:298–303PubMedGoogle Scholar
  32. Sugarbaker DJ, Gill RR, Yeap BY et al (2013) Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg 45:955–963CrossRefGoogle Scholar
  33. Sugarbaker DJ, Richards WG, Bueno R (2014) Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients. Ann Surg 260:577–580. discussion pp 80–82CrossRefPubMedPubMedCentralGoogle Scholar
  34. Taioli E, Wolf AS, Camacho-Rivera M et al (2014) Women with malignant pleural mesothelioma have a threefold better survival rate than men. Ann Thorac Surg 98:1020–1024CrossRefPubMedGoogle Scholar
  35. Taioli E, Wolf AS, Camacho-Rivera M et al (2015a) Determinants of survival in malignant pleural mesothelioma: a Surveillance, Epidemiology, and End Results (SEER) study of 14,228 Patients. PLoS One 10:e0145039CrossRefPubMedPubMedCentralGoogle Scholar
  36. Taioli E, Wolf AS, Flores RM (2015b) Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg 99:472–480CrossRefPubMedGoogle Scholar
  37. Taioli E, Wolf AS, Moline JM et al (2015c) Frequency of surgery in black patients with malignant pleural mesothelioma. Dis Markers 2015:282145CrossRefPubMedPubMedCentralGoogle Scholar
  38. Tilleman TR, Richards WG, Zellos L et al (2009) Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 138:405–411CrossRefPubMedGoogle Scholar
  39. Treasure T, Lang-Lazdunski L, Waller D et al (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12:763–772CrossRefPubMedPubMedCentralGoogle Scholar
  40. Weder W, Kestenholz P, Taverna C et al (2004) Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 22:3451–3457CrossRefPubMedGoogle Scholar
  41. Weder W, Stahel RA, Bernhard J et al (2007) Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18:1196–1202CrossRefPubMedGoogle Scholar
  42. Wolf AS, Daniel J, Sugarbaker DJ (2009) Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg 21:132–148CrossRefPubMedGoogle Scholar
  43. Wolf AS, Jacobson FL, Tilleman TR et al (2010a) Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring. Eur J Cardiothorac Surg 37:770–775CrossRefPubMedGoogle Scholar
  44. Wolf AS, Richards WG, Tilleman TR et al (2010b) Characteristics of malignant pleural mesothelioma in women. Ann Thorac Surg 90:949–956. discussion p 956CrossRefPubMedGoogle Scholar
  45. Wolf AS, Gill RR, Baldini EH et al (2012) Patterns of recurrence following pleurectomy/decortication for malignant pleural mesothelioma. In: Abstracts of 11th International Conference of the International Mesothelioma Interest GroupGoogle Scholar
  46. Yan TD, Boyer M, Tin MM et al (2009) Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. J Thorac Cardiovasc Surg 138:619–624CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Mount Sinai Health System, Thoracic Surgery DepartmentIcahn School of MedicineNew YorkUSA

Personalised recommendations